JobsDefinium Therapeutics
Definium Therapeutics logo

Definium Therapeutics

Biotechnology Research
141 employeesNew York, NYEst. 2019
AI + human review

About Definium Therapeutics

Definium Therapeutics (formerly MindMed) is a biotech company forging a new era of psychiatry by applying precision to psychedelic medicine. We develop science-led, accessible treatment approaches designed to open new routes for brain health and help people reclaim more vibrant lives. From day one, we have been powered by a radical idea: treatments for anxiety and depression should bring real relief. Together we’re moving psychiatry forward— beyond better, into a boundless future. Definium Therapeutics trades on the NASDAQ under the symbol DFTX.

Open roles (14)

US roles only: 1 · All: 14

Company details

Employees
141
Industry
Biotechnology Research
Headquarters
New York, NY
Founded
2019